Changing the Face of Chemical Sensing

About us

Here at Affinomer we strive to break the current paradigm in point-of-care chemical sensing, offering a radical new sensing technology that propels the field toward. Unlike the technologies traditionally associated with point-of-care analysis (antibodies), here at Affinomer, we are utilizing Molecularly Imprinted Polymers (MIPs) as an emerging synthetic alternative that offers great promise. Offering high tunability, robustness and stability, we seek to implement MIPs into a plethora of rapid chemical tests that can be utilized across many sectors (Dairy, Healthcare, Agriculture, Beverages, etc.).

Currently, MIP-based biosensors are predominantly bound to the research lab, with hundreds of research articles released every year highlighting their potential. However, to date, there are few commercial ventures adopting these synthetic marvels, meaning these important developments remain an academic exercise. We wish to change this fact, bringing the knowledge from the lab to the commercial world.

Our team is uniquely qualified, having high levels of expertise in MIP synthesis, biosensor design, and associated readout technologies, enabling Affinomer to pioneer the latest advancements in the field and bring them to market. Our focus is to scale MIP technology like no one has before, incorporating it into simple sensing devices that offer high quality, robust, reliable and cost-effective chemical sensing.

purple cells
purple cells
woman in white long sleeve shirt sitting on chair
woman in white long sleeve shirt sitting on chair


High Affinity


The physical characteristics of MIPs can be tailored specifically towards an analyte of interest.

Due to the imprinting process, MIPs have high affinity towards the imprinted species.

Consisting of highly cross-linked polymer, MIPs are resistant to extreme pH and temperature unlike traditional biological affinity reagents.

Applications of MIPs

Due to the versatile nature of MIPs they have the potential to be integrated as "synthetic receptors" into lateral flow devices, biosensing platforms, and IVD (In Vitro Diagnostics) processing platforms for sample preparation, purification and even enrichment. Additionally, MIPs have demonstrated huge potential in more traditional chemical separation, catalysis, and even targeted drug release,

Lateral flow
Assay formats

Affinomer B.V. Oxfordlaan 70, 6229 EV, Maastricht Copyright 2023